Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 13, Issue 6, Pages 245-250Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S1043-2760(02)00603-3
Keywords
-
Categories
Funding
- NCI NIH HHS [CA80920] Funding Source: Medline
- NIEHS NIH HHS [ES09555, ES10154] Funding Source: Medline
Ask authors/readers for more resources
Prolactin (PRL) has a dual function-as a circulating hormone and as a cytokine. This understanding is based on PRL production and distinct regulation in extrapituitary sites, its binding to membrane receptors of the cytokine receptor superfamily, and activation of signaling pathways that promote cell growth and survival. There is increasing evidence that PRL plays a role in several types of cancer in reproductive and non-reproductive tissues via local production or accumulation. The expression of both PRL and its receptor in human cancer cell lines of diverse origin lends further support to its action as an autocrine/paracrine growth factor. Establishment of PRL as an active participant in tumorigenesis should inspire the development of novel therapies aimed at reducing tumor growth by suppressing PRL production or by blocking its receptors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available